
浏览全部资源
扫码关注微信
400042 重庆,陆军军医大学(第三军医大学)大坪医院高血压内分泌科,全军内分泌代谢病中心,重庆市高血压研究所
[ 祝之明,E-mail:zhuzm@yahoo.com ZHU Zhiming, E-mail:zhuzm@yahoo.com
收稿:2019-06-25,
修回:2019-08-24,
纸质出版:2019-11-15
移动端阅览
洪阳宁, 孙芳, 张和轩, 等. 化学发光法和放射免疫法对原发性醛固酮增多症的诊断效果比较[J]. 第三军医大学学报, 2019,(21):2080-2086.
Yangning HONG, Fang SUN, Hexuan ZHANG, et al. Diagnostic efficacy of chemiluminescence immunoassay versus radioimmunoassay in screening primary aldosteronism[J]. Journal of Third Military Medical University, 2019, (21): 2080-2086.
洪阳宁, 孙芳, 张和轩, 等. 化学发光法和放射免疫法对原发性醛固酮增多症的诊断效果比较[J]. 第三军医大学学报, 2019,(21):2080-2086. DOI: 10.16016/j.1000-5404.201906209.
Yangning HONG, Fang SUN, Hexuan ZHANG, et al. Diagnostic efficacy of chemiluminescence immunoassay versus radioimmunoassay in screening primary aldosteronism[J]. Journal of Third Military Medical University, 2019, (21): 2080-2086. DOI: 10.16016/j.1000-5404.201906209.
目的
2
比较化学发光法和放射免疫法检测醛固酮与肾素的敏感性、特异性,探索筛查原发性醛固酮增多症的最佳检测方法和指标。
方法
2
横断面研究设计入选2018年1-10月就诊于我科并确诊的原发性醛固酮增多症60例(男性占53.3%,平均年龄50岁),同时入选基线资料匹配的原发性高血压82例(男性占50.0%,平均年龄50岁),健康对照者114例(男性占38.6%,平均年龄46岁)。应用化学发光法与放射免疫法分别检测血浆醛固酮浓度和血浆肾素浓度/肾素活性。利用相关性分析评价两种方法的筛查价值,同时通过绘制受试者工作特征曲线(ROC)对两种方法测得的血浆醛固酮浓度、血浆肾素浓度(或活性)、血浆醛固酮/直接肾素浓度比值(ratio of aldosterone/diret rennin concentration
ADRR)、血浆醛固酮/血浆肾素活性比值(ratio of aldosterone/plasma rennin activity
ARR)及两两联合指标进行评价,计算敏感性和特异性,确定最佳切点值。
结果
2
血浆肾素活性和直接肾素浓度高度相关(
r
=0.880 4
P
<
0.001),而两种方法测得的血浆醛固酮浓度的相关性欠佳(
r
=0.365 0
P
<
0.001)。各项筛查指标中ADRR的敏感性最高(91.53%),联合血浆醛固酮浓度(化学发光法)可显著提高诊断的特异性(96.49%)。平均年龄50岁的原发性醛固酮增多症患者中,ADRR筛查切点为12(pg·mL
-1
)/(μU·mL
-1
),ARR的筛查切点为20 (ng·dL
-1
)/(ng·mL
-1
·h
-1
)。
结论
2
化学发光法检测原发性醛固酮增多症筛查指标的价值优于放射免疫法,联合血浆醛固酮浓度(化学发光法)和ADRR指标的诊断特异性最佳。
Objective
2
To compare the sensitivity and specificity of chemiluminescence immunoassay (CLIA) and radioimmunoassay (RIA) in detection of aldosterone and renin
and to explore the optional detection methods and indicators for screening primary aldosteronism (PA).
Methods
2
A cross-sectional study was carried on 60 PA patients (with males accounting for 53.3% and at a median age of 50 years) diagnosed in our department from January to October 2018. Another baseline-matched 82 patients with essential hypertension (with males accounting for 50.0% and at a median age of 50 years) and 114 healthy controls (males accounting for 38.6% and at a median age of 46 years) at the same period were also recruited in this study. The plasma aldosterone concentration and renin concentration/renin activity were measured by CLIA and RIA respectively. The screening value of the 2 methods was evaluated by correlation analysis. Meanwhile
the plasma aldosterone concentration
plasma renin concentration (or activity)
ratio of aldosterone/direct rennin concentration (ADRR)
ratio of aldosterone/plasma rennin activity (ARR) and 2 combined indicators were measured by receiver operating characteristic (ROC) curve
to calculate sensitivity and specificity and determine the optimal cut-off point.
Results
2
There was a high correlation between plasma renin activity and direct renin concentration (
r
=0.880 4
P
<
0.001)
but the correlation between plasma aldosterone concentration measured by the 2 methods was not good (
r
=0.365 0
P
<
0.001). The sensitivity of ADRR was the highest (91.53%) among all screening indices
and the specificity of diagnosis was significantly improved by combining plasma aldosterone concentration (CLIA
96.49%). Among PA at an average age of 50 years
ADRR screening cut-off point was 12 (pg·mL
-1
)/(μU·mL
-1
)
and ARR screening cut-off point was 20 (ng·dL
-1
)/(ng·mL
-1
·h
-1
).
Conclusion
2
CLIA is superior to RIA in detection of screening indices for PA. The diagnostic specificity of combined plasma aldosterone concentration (CLIA) and ADRR indices is the best.
MONTICONE S, BURRELLO J, TIZZANI D, et al . Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice[J ] . J Am Coll Cardiol, 2017, 69(14): 1811-1820. DOI:10.1016/j.jacc.2017.01.052.
VAIDYA A, MULATERO P, BAUDRAND R, et al . The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment[J ] . Endocr Rev, 2018, 39(6): 1057-1088. DOI:10.1210/er.2018-00139.
FUNDER J W, CAREY R M, MANTERO F, et al . The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline[J ] . J Clin Endocrinol Metab, 2016, 101(5): 1889-1916. DOI:10.1210/jc.2015-4061.
NANBA K, TAMANAHA T, NAKAO K, et al . Confirmatory testing in primary aldosteronism[J ] . J Clin Endocrinol Metab, 2012, 97(5): 1688-1694. DOI:10.1210/jc.2011-2504.
BURRELLO J, MONTICONE S, BUFFOLO F, et al . Diagnostic accuracy of aldosterone and renin measurement by chemiluminescent immunoassay and radioimmunoassay in primary aldosteronism[J ] . J Hypertens, 2016, 34(5): 920-927. DOI:10.1097/HJH.0000000000000880.
SEALEY J E, GORDON R D, MANTERO F. Plasma renin and aldosterone measurements in low renin hypertensive states[J]. Trends Endocrinol Metab, 2005, 16(3): 86-91. DOI:10.1016/j.tem.2005.02.006.
ROSSI G P, CEOLOTTO G, ROSSITTO G, et al . Prospective validation of an automated chemiluminescence-based assay of renin and aldosterone for the work-up of arterial hypertension[J ] . Clin Chem Lab Med, 2016, 54(9): 1441-1450. DOI:10.1515/cclm-2015-1094.
AHMED A H, COWLEY D, WOLLEY M, et al . Seated saline suppression testing for the diagnosis of primary aldosteronism: a preliminary study[J ] . J Clin Endocrinol Metab, 2014, 99(8): 2745-2753. DOI:10.1210/jc.2014-1153.
SONG Y, YANG S M, HE W W, et al . Confirmatory tests for the diagnosis of primary aldosteronism: A prospective diagnostic accuracy study[J ] . Hypertension, 2018, 71(1): 118-124. DOI:10.1161/HYPERTENSIONAHA.117.10197.
GLINICKI P, JESKE W, BEDNAREK-PAPIERSKA L, et al . The ratios of aldosterone / plasma renin activity (ARR) versus aldosterone / direct renin concentration (ADRR)[J ] . J Renin Angiotensin Aldosterone Syst, 2015, 16(4): 1298-1305. DOI:10.1177/1470320313519487.
孙明芳, 杨珊, 何小群, 等.基于血浆醛固酮/肾素浓度比的联合策略在原发性醛固酮增多症中的筛查价值[J].军事医学, 2015, 39(4): 279-283. DOI: 10.7644/j.issn.1674-9960.2015.04.011.
SUN M F, YANG S, HE X Q, et al . Value of combination strategy based on plasma aldosterone / renin concentration ratio in screening of primary aldosteronism[J ] . Mil Med Sci, 2015, 39(4): 279-283. DOI: 10.7644/j.issn.1674-9960.2015.04.011.
赖凤华, 曹筱佩, 林慧美, 等.两种血浆肾素、醛固酮检测方法对原发性醛固酮增多症筛查效率的评价[J].中华高血压杂志, 2015, 23(2): 150-153. DOI:10.16439/j.cnki.1673-7245.2015.02.020.
LAI F H, CAO X P, LIN H M, et al . Comparison of plasma renin and aldosterone measured by radioimmunoassay and chemiluminescence immunoassay in screening primary aldosteronism[J ] . Chin J Hypertens, 2015, 23(2): 150-153. DOI:10.16439/j.cnki.1673-7245.2015.02.020.
梁霞, 王小静, 余文珮, 等.原发性醛固酮增多症诊断切点的研究及临床应用[J].第三军医大学学报, 2015, 37(11): 1146-1149. DOI:10.16016/j.1000-5404.201501193.
LIANG X, WANG X J, YU W P, et al . Determination of optimal cut-off point for primary aldosteronism and its diagnostic value in clinical practice[J ] . J Third Mil Med Univ, 2015, 37(11): 1146-1149. DOI:10.16016/j.1000-5404.201501193.
MA L Q, SONG Y, MEI M, et al . Age-related cutoffs of plasma aldosterone/renin concentration for primary aldosteronism screening[J ] . Int J Endocrinol, 2018, 2018: 8647026. DOI:10.1155/2018/8647026.
NANBA K, VAIDYA A, WILLIAMS G H, et al . Age-related autonomous aldosteronism[J ] . Circulation, 2017, 136(4): 347-355. DOI:10.1161/CIRCULATIONAHA.117.028201.
王芳, 马文君, 丛洪瀛, 等.化学发光法测定血浆醛固酮和肾素浓度的参考区间及筛查原发性醛固酮增多症的价值[J].中国分子心脏病学杂志, 2017, 17(1): 1970-1973. DOI:10.16563/j.cnki.1671-6272.2017.02.007.
WANG F, MA W J, CONG H Y, et al . The reference interval of plasma aldosterone and renin concentration detected by chemiluminescence immunoassay and the performance evaluation in screening primary aldosteronism[J ] . Mol Cardiol China, 2017, 17(1): 1970-1973. DOI:10.16563/j.cnki.1671-6272.2017.02.007.
LENDERS J W M, EISENHOFER G, REINCKE M. Subtyping of patients with primary aldosteronism: an update[J]. Horm Et Metab, 2017, 49(12): 922-928. DOI:10.1055/s-0043-122602.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621